Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

UC San Diego Researcher Receives $2.5 million Award from the National Institute on Drug Abuse

 

July 24, 2012  |  

Davey Smith, MD, associate professor of medicine in the Division of Infectious Diseases at the University of California, San Diego School of Medicine and the VA San Diego Health System is one of three recipients of the 2012 Avant-Garde Award for HIV/AIDS research.  This prestigious award, announced today by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is intended to stimulate high-impact research that may lead to groundbreaking opportunities for the prevention and treatment of HIV/AIDS in drug abusers.

Davey Smith

Davey Smith, MD

Smith will receive $500,000 per year for the next five years to support a project for HIV prevention for drug users and other high-risk groups. His research group will work to develop a system that integrates patient demographics, geographic location, drug use and HIV strain in order to map patterns of new HIV infections as they occur.  Such a system is designed to ensure quick delivery of prevention resources that are tailored to specific groups at risk for HIV, with the goal of stopping transmission of the disease, particularly among illicit substance users.

“We believe this could be the key to ending HIV transmission in some of the most at-risk populations in San Diego and, in turn, other communities,” said Smith.

Smith is a translational research virologist who works both at the UC San Diego Antiviral Research Center, where he is medical director of the Early Intervention Program, and as director of the Center for AIDS Research (CFAR) Translational Virology Core. His primary research focus is on the transmission of HIV and finding new ways to interrupt the spread of the disease.

In 2010, Smith was one of two recipients of the HIV Medicine Association’s 2010 HIV Research Award, recognizing up-and-coming HIVMA members who have made outstanding contributions to HIV medicine early in their careers.  He is also a member of the San Diego County HIV Planning Council, where he chairs the standards of care committee.

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu


Related Specialties

AIDS/HIV+



Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...


Share This Article



Follow Us: